bpac home
Search  Publication   Category 

Antipsychotics in dementia: Best Practice Guide

 Introduction, Rationale and Key Points 
 Behavioural and Psychological Symptoms of Dementia (BPSD) 
 Assessment of patients with BPSD 
 Non-pharmacological treatment of BPSD 
 Pharmacological treatment of BPSD 
 Adverse effects of antipsychotics 
 Dementia with Lewy Bodies (DLB) 
 Other medicines for BPSD 
 Treatment of comorbid conditions in patients with dementia 
 References 
 Appendix 
  Click here for a PDF

Other medicines for BPSD

Cholinesterase inhibitors
Cholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine) may be considered for the treatment of psychotic symptoms, agitation or aggression if a non-pharmacological approach is inappropriate or has been ineffective, and antipsychotics are inappropriate or have been ineffective.13

Benzodiazepines (e.g. diazepam, lorazepam) and zopiclone
Generally these should be avoided as they can increase confusion, impair cognition and gait and cause sedation. The risk of a fall may be increased especially if combined with other medicines that cause sedation or postural hypotension. Benzodiazepines cause disinhibition and have the potential to worsen behavioural disturbances. If a benzodiazepine is considered necessary for severe agitation this should be reviewed and preferably stopped after a maximum of two weeks.4 Zopiclone may also be useful but carries the same prescribing precautions as the benzodiazepines. A meta-analysis of sedative use in older people with insomnia showed that the experience of an adverse effect was about twice as likely as an improvement in sleep quality.19

Anticonvulsants
Sodium valproate and carbamazepine have been used for agitated behaviour associated with dementia but the supporting evidence is very weak. Both have a significant potential for serious adverse effects and drug interactions and are not generally recommended.

Page  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 Page 8

Submit a comment about this article